Literature DB >> 17223022

Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device.

S Charlton1, N S Jones, S S Davis, L Illum.   

Abstract

There is an increasing need to identify novel approaches by which to improve the efficiency of drug transport from the nasal cavity (olfactory region) to the CNS, especially for treatment of central nervous system disorders. It is suggested, that one approach is the combination of active targeting of a bioadhesive formulation, that will retain the drug at the absorption site, potentially in combination with, an absorption enhancer. Two low methylated pectins, LM-5 and LM-12 were selected for evaluation as drug delivery systems, due to their ability to gel in the nasal cavity and their bioadhesive characteristics, together with chitosan G210, which acts both as a bioadhesive material and as an efficient absorption enhancer. It was found that all of the bioadhesive formulations were able to reach the olfactory region in the nasal cavity of human volunteers when delivered using a simple nasal drop device. Furthermore, the formulations displayed a significantly increased residence time on the epithelial surface. This was in contrast to a non-bioadhesive control delivered with the same device. In contrast, a pectin formulation administered with a nasal spray system did not show an increase in residence time in the olfactory region. It was further shown that the reproducibility of olfactory delivery of a polymer formulation was significantly better intra-subject than inter-subject.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17223022     DOI: 10.1016/j.ejps.2006.11.018

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  17 in total

1.  Recent advances in nanotechnology based drug delivery to the brain.

Authors:  Li-Na Lin; Qun Liu; Lei Song; Fang-Fang Liu; Jin-Xiu Sha
Journal:  Cytotechnology       Date:  2010-08-11       Impact factor: 2.058

2.  Nanomaterials in controlled drug release.

Authors:  Xin-Jun Cai; Ying-Ying Xu
Journal:  Cytotechnology       Date:  2011-07-01       Impact factor: 2.058

3.  Thermally triggered mucoadhesive in situ gel of loratadine: β-cyclodextrin complex for nasal delivery.

Authors:  Reena M P Singh; Anil Kumar; Kamla Pathak
Journal:  AAPS PharmSciTech       Date:  2013-01-29       Impact factor: 3.246

4.  Intranasal In Situ Gel of Apixaban-Loaded Nanoethosomes: Preparation, Optimization, and In Vivo Evaluation.

Authors:  Ahmed A El-Shenawy; Reda A Mahmoud; Essam A Mahmoud; Mohamed S Mohamed
Journal:  AAPS PharmSciTech       Date:  2021-05-04       Impact factor: 3.246

5.  CriticalSorb™: enabling systemic delivery of macromolecules via the nasal route.

Authors:  Andrew L Lewis; Faron Jordan; Lisbeth Illum
Journal:  Drug Deliv Transl Res       Date:  2013-02       Impact factor: 4.617

6.  Chlorpheniramine maleate containing chitosan-based nanoparticle-loaded thermosensitive in situ gel for management in allergic rhinitis.

Authors:  Manish Kumar; Pooja Upadhayay; Ravi Shankar; Monika Joshi; Shailendra Bhatt; Anuj Malik
Journal:  Drug Deliv Transl Res       Date:  2019-12       Impact factor: 4.617

7.  Aerosol-stable peptide-coated liposome nanoparticles: a proof-of-concept study with opioid fentanyl in enhancing analgesic effects and reducing plasma drug exposure.

Authors:  John D Hoekman; Pramod Srivastava; Rodney J Y Ho
Journal:  J Pharm Sci       Date:  2014-06-06       Impact factor: 3.534

8.  Increased brain radioactivity by intranasal P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels.

Authors:  Ana Paula Perez; Cecilia Mundiña-Weilenmann; Eder Lilia Romero; Maria Jose Morilla
Journal:  Int J Nanomedicine       Date:  2012-03-12

9.  Chitosan encapsulation modulates the effect of capsaicin on the tight junctions of MDCK cells.

Authors:  M Kaiser; S Pereira; L Pohl; S Ketelhut; B Kemper; C Gorzelanny; H-J Galla; B M Moerschbacher; F M Goycoolea
Journal:  Sci Rep       Date:  2015-05-13       Impact factor: 4.379

10.  Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?

Authors:  Matthias van Woensel; Nathalie Wauthoz; Rémi Rosière; Karim Amighi; Véronique Mathieu; Florence Lefranc; Stefaan W van Gool; Steven de Vleeschouwer
Journal:  Cancers (Basel)       Date:  2013-08-14       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.